Erythropoietin Treatment in Patients With Systolic Left Ventricular Dysfunction, Mild Anemia and Normal Renal Function

Phase 4UnknownNCT00418119

Rabin Medical Center10 enrolled

Overview

Erythropoietin Treatment in Patients with systolic left ventricular dysfunction, mild anemia and normal renal function

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Heart Failure

Interventions

erythropoietinDRUG

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Ischemic heart disease * Systolic lv dysfunction * Mild anemia * Normal renal function * Stable condition Exclusion Criteria: * Pregnancy * Unstable condition * Under 18 years old

Locations (1)

Cardiology Department, Rabin Medical Center

Petah Tikva, Petah Tikva, Israel

Central Contacts

Tuvia Ben Gal, MD

CONTACT

972-522757616 bengalt@clalit.org.il

Daniel Murninkas, MD

CONTACT

972-39376930 murninkasd@clalit.org.il

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.